Drug Trial Radar · NCT03745638
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
631
Actual
Start
Dec 20, 2018
Primary completion
Dec 23, 2019
Study completion Dec 1, 2020
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Nov 19, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of twice daily ruxolitinib cream in adolescents and adults with Atopic Dermatitis (AD).
Conditions
- Atopic Dermatitis
Interventions
Ruxolitinib CreamDrug
Ruxolitinib cream applied topically to the affected area as a thin film twice daily.
Vehicle CreamDrug
Matching vehicle cream applied topically to the affected area as a thin film twice daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved Investigator's Global Assessment - Treatment Success (IGA-TS) at Week 8Time frame: Baseline to Week 8
Locations
79 sites in 7 countries. Site status is shown where the registry gives one.
Cahaba Dermatology
Birmingham, Alabama
Elite Clinical Studies
Phoenix, Arizona
First OC Dermatology
Fountain Valley, California
Dermatology Research Associates
Los Angeles, California
Dermatology Specialists Inc
Oceanside, California
Integrated Research Group Inc.
Riverside, California
Advanced Rx Clinical Research
Westminster, California
Clearlyderm Boca Raton - BTC - PPDS
Boca Raton, Florida
Olympian Clinical Research
Largo, Florida
Acevedo Clinical Research
Miami, Florida
Well Pharma Medical Research Corporation
Miami, Florida
AdvancedPharma CR LLC
Miami, Florida
University of South Florida
Tampa, Florida
ForCare Clinical Research
Tampa, Florida
Metabolic Research Institute Inc
West Palm Beach, Florida
Aeroallergy Research Lab Of Savannah
Savannah, Georgia
Clinical Research Atlanta - ERN-PPDS
Stockbridge, Georgia
Sneeze Wheeze and Itch Associates LLC
Normal, Illinois
Dawes Fretzin Clinical Research Group LLC
Indianapolis, Indiana
DS Research
New Albany, Indiana
Kansas City Dermatology P.A.
Overland Park, Kansas
Skin Sciences, PLLC
Louisville, Kentucky
Michael W Simon MD
Nicholasville, Kentucky
DermAssociates
Rockville, Maryland
Henry Ford Medical Center
Detroit, Michigan
JDR Dermatology Research
Las Vegas, Nevada
Forest Hills Dermatology Group
Forest Hills, New York
Sadick Dermatology
New York, New York
Wake Research Associates, LLC
Raleigh, North Carolina
Ohio Pediatric Research Assn Inc
Huber Heights, Ohio
Central Sooner Research
Norman, Oklahoma
Cyn3rgy Research - Clinedge - PPDS
Gresham, Oregon
Clinical Research Institute Of Southern Oregon - Crisor
Medford, Oregon
Oregon Medical Research Center PC
Portland, Oregon
Oregon Health and Science University
Portland, Oregon
Synexus Clinical Research Us Inc. Greer
Greer, South Carolina
Alliance for Multispecialty Research, LLC
Knoxville, Tennessee
Family Medicine Associates Of Texas
Carrollton, Texas
Progressive Clinical Research PA
San Antonio, Texas
Jordan Valley Medical Center
West Jordan, Utah
Showing 40 of 79 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.